Impact of the COVID-19 Pandemic on Cancer Clinical Trials

Judy C. Boughey; Rebecca A. Snyder; Olga Kantor; Linda Zheng; Akhil Chawla; Toan T. Nguyen; Shauna L. Hillman; Olwen M. Hahn; Sumithra J. Mandrekar; Christina L. Roland

doi:10.1245/s10434-021-10406-2

Impact of the COVID-19 Pandemic on Cancer Clinical Trials

Judy C. Boughey, Rebecca A. Snyder, Olga Kantor, Linda Zheng, Akhil Chawla, Toan T. Nguyen, Shauna L. Hillman, Olwen M. Hahn, Sumithra J. Mandrekar, Christina L. Roland

Research output: Contribution to journal › Article › peer-review

Abstract

The COVID-19 pandemic has had widespread impact on healthcare, resulting in modifications to how we perform cancer research, including clinical trials for cancer. The impact of some healthcare workers and study coordinators working remotely and patients minimizing visits to medical facilities impacted clinical trial participation. Clinical trial accrual dropped at the onset of the pandemic, with improvement over time. Adjustments were made to some trial protocols, allowing telephone or video-enabled consent. Certain study activities were permitted to be performed by local healthcare providers or at local laboratories to maximize patients’ ability to continue on study during these challenging times. We discuss the impact of COVID-19 on cancer clinical trials and changes at the local, cooperative group, and national level.

Original language	English (US)
Pages (from-to)	7311-7316
Number of pages	6
Journal	Annals of surgical oncology
Volume	28
Issue number	12
DOIs	https://doi.org/10.1245/s10434-021-10406-2
State	Published - Nov 2021

ASJC Scopus subject areas

Surgery
Oncology

Access to Document

10.1245/s10434-021-10406-2

Cite this

@article{83c17e7238954a1784dc46fbba46ce36,

title = "Impact of the COVID-19 Pandemic on Cancer Clinical Trials",

abstract = "The COVID-19 pandemic has had widespread impact on healthcare, resulting in modifications to how we perform cancer research, including clinical trials for cancer. The impact of some healthcare workers and study coordinators working remotely and patients minimizing visits to medical facilities impacted clinical trial participation. Clinical trial accrual dropped at the onset of the pandemic, with improvement over time. Adjustments were made to some trial protocols, allowing telephone or video-enabled consent. Certain study activities were permitted to be performed by local healthcare providers or at local laboratories to maximize patients{\textquoteright} ability to continue on study during these challenging times. We discuss the impact of COVID-19 on cancer clinical trials and changes at the local, cooperative group, and national level.",

author = "Boughey, {Judy C.} and Snyder, {Rebecca A.} and Olga Kantor and Linda Zheng and Akhil Chawla and Nguyen, {Toan T.} and Hillman, {Shauna L.} and Hahn, {Olwen M.} and Mandrekar, {Sumithra J.} and Roland, {Christina L.}",

note = "Publisher Copyright: {\textcopyright} 2021, Society of Surgical Oncology.",

year = "2021",

month = nov,

doi = "10.1245/s10434-021-10406-2",

language = "English (US)",

volume = "28",

pages = "7311--7316",

journal = "Annals of surgical oncology",

issn = "1068-9265",

publisher = "Springer New York",

number = "12",

}

TY - JOUR

T1 - Impact of the COVID-19 Pandemic on Cancer Clinical Trials

AU - Boughey, Judy C.

AU - Snyder, Rebecca A.

AU - Kantor, Olga

AU - Zheng, Linda

AU - Chawla, Akhil

AU - Nguyen, Toan T.

AU - Hillman, Shauna L.

AU - Hahn, Olwen M.

AU - Mandrekar, Sumithra J.

AU - Roland, Christina L.

PY - 2021/11

Y1 - 2021/11

N2 - The COVID-19 pandemic has had widespread impact on healthcare, resulting in modifications to how we perform cancer research, including clinical trials for cancer. The impact of some healthcare workers and study coordinators working remotely and patients minimizing visits to medical facilities impacted clinical trial participation. Clinical trial accrual dropped at the onset of the pandemic, with improvement over time. Adjustments were made to some trial protocols, allowing telephone or video-enabled consent. Certain study activities were permitted to be performed by local healthcare providers or at local laboratories to maximize patients’ ability to continue on study during these challenging times. We discuss the impact of COVID-19 on cancer clinical trials and changes at the local, cooperative group, and national level.

AB - The COVID-19 pandemic has had widespread impact on healthcare, resulting in modifications to how we perform cancer research, including clinical trials for cancer. The impact of some healthcare workers and study coordinators working remotely and patients minimizing visits to medical facilities impacted clinical trial participation. Clinical trial accrual dropped at the onset of the pandemic, with improvement over time. Adjustments were made to some trial protocols, allowing telephone or video-enabled consent. Certain study activities were permitted to be performed by local healthcare providers or at local laboratories to maximize patients’ ability to continue on study during these challenging times. We discuss the impact of COVID-19 on cancer clinical trials and changes at the local, cooperative group, and national level.

UR - http://www.scopus.com/inward/record.url?scp=85110873428&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85110873428&partnerID=8YFLogxK

U2 - 10.1245/s10434-021-10406-2

DO - 10.1245/s10434-021-10406-2

M3 - Article

C2 - 34236550

AN - SCOPUS:85110873428

SN - 1068-9265

VL - 28

SP - 7311

EP - 7316

JO - Annals of surgical oncology

JF - Annals of surgical oncology

IS - 12

ER -

Impact of the COVID-19 Pandemic on Cancer Clinical Trials

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this